Amiloride, fluoxetine or riluzole to reduce brain volume loss in secondary progressive multiple sclerosis: the MS-SMART four-arm RCT (2020)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3310/eme07030
PubMed Identifier: 32453521
Publication URI: http://europepmc.org/abstract/MED/32453521
Type: Journal Article/Review
Parent Publication: Efficacy and Mechanism Evaluation
Issue: 3